INFLUENCE OF VITAMIN-D3 ON INTESTINAL CALCIUM-ABSORPTION AND ON MINERAL METABOLISM IN PATIENTS WITH CHRONIC-RENAL-FAILURE AND HEMODIALYSIS

被引:0
作者
FUNFSTUCK, R [1 ]
STEIN, G [1 ]
ABENDROTH, K [1 ]
TIETZ, U [1 ]
KOKOT, F [1 ]
BAGHDADI, F [1 ]
MULLER, A [1 ]
GUNTHER, K [1 ]
机构
[1] UNIV JENA,INNERE MED KLIN,NEPHROL ABT,O-6900 JENA,GERMANY
关键词
CHRONIC RENAL FAILURE; CA ABSORPTION; INFLUENCE OF VITAMIN-D2 AND VITAMIN-D3;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Impairment of intestinal calcium-absorption (Ca) can be observed already in early stage of renal failure. An investigation of 68 healthy control-persons and of patients with glomerulonephritis and pyelonephritis showed a deterioration of Ca-absorption with increasing renal insufficiency. These alterations are due to impairment of vitamin D3-metabolism. The lack of active metabolites of vitamin D, especially 1,25 (OH)2D3, leads to a decreased synthesis of Ca-binding proteine, calmodulin and other different systems of enzymes in the mucosal cells. These are factors which are considered to be relevant for Ca-absorption. Although these reactions according to receptor specificity are dependent of 1,25(OH)2D3-level, they can also be influenced by vitamin D2 and vitamin D3. In 29 patients, - 16 with chronic renal failure and 13 undergoing hemodialysis - 47 Ca-absorption-rate was markedly improved by daily application of 40000 IU vitamin D2 or vitamin D3 over 4 weeks: vitamin D2-group: fR (absorption-rate): 6.8 --> 16.9. - vitamin D3-group: fR (absorption-rate): 23.9 --> 27.4. Increment of the vitamin D-dosage to 80000 IU per day yielded no further benefit. Parallel to the improved intestinal Ca-absorption serum-Ca tot and serum-Ca ion normalized. The impairment of Ca-metabolismus could be better influenced by vitamin D3 than vitamin D2. In 9 patients with chronic renal failure the parameters of mineral-metabolism were normalized (serum Ca ion: 0.98 +/- 0.01 - 1.10 +/- 0.03 under longterm application of 20000 IU vitamin D3 per day over 6 months. In 11 hemodialysis patients-despite of increase of serum-Ca (Ca ion.: 1.02 +/- 0.01 --> 1.17 + 0.03 mmol/l) and increase of serum 25-(OH)D3 (28.9 + 18.2 --> 147.2 + 124.7-mu-g/ml) the hyperparathyroidism was not suppressed effectively: Enhanced PTH, alkaline phosphatase and hydroxyproline-excretion could not be corrected. As a consequence of knowledge about the impaired intestinal Ca-absorption in chronic renal failure the necessity of vitamin D-therapy is given. It should be started in an early stage of renal failure; once the stage of dialysis is reached, there is no effective control of the complex disorder of regulation by these vitamin D-agents any more.
引用
收藏
页码:303 / 310
页数:8
相关论文
共 44 条
  • [31] The Influence Of Family Support To Patients'anxiety Of Chronic Renal Failure Withexperience Of Hemodialysis At The Hemodialysis Unit Of Ulin Hospital Banjarmasin
    Al Kahfi, Rina
    Rahman, Subhannur
    Palimbo, Adriana
    Sari, Nina Novita
    PROCEEDINGS OF THE 2ND SARI MULIA INTERNATIONAL CONFERENCE ON HEALTH AND SCIENCES 2017 (SMICHS 2017), 2017, 6 : 219 - 226
  • [32] CHANGES IN BRAIN NATRIURETIC PEPTIDE AND ATRIAL-NATRIURETIC-PEPTIDE PLASMA-CONCENTRATIONS DURING HEMODIALYSIS IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    HAUG, C
    METZELE, A
    STEFFGEN, J
    GRUNERT, A
    HORMONE AND METABOLIC RESEARCH, 1994, 26 (05) : 246 - 249
  • [33] EFFECTS OF HEMODIALYSIS AND CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS ON ABNORMALITIES OF ION-TRANSPORT IN-VIVO IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    BREARLEY, CJ
    ARONSON, JK
    BOON, NA
    RAINE, AEG
    CLINICAL SCIENCE, 1993, 85 (06) : 725 - 731
  • [34] EVALUATION OF THE PROTEOLYTIC ACTIVITY OF FACTOR-D ACCUMULATED AS AN ACTIVE SERINE-PROTEASE IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    INAGI, R
    MIYATA, T
    ODA, O
    MAEDA, K
    INOUE, K
    NEPHRON, 1994, 66 (03): : 285 - 290
  • [35] EFFECT OF BEZAFIBRATE ON LIPOPROTEIN (A) AND TRIGLYCERIDE-RICH LIPOPROTEINS, INCLUDING INTERMEDIATE-DENSITY LIPOPROTEINS, IN PATIENTS WITH CHRONIC-RENAL-FAILURE RECEIVING HEMODIALYSIS
    PELEGRI, A
    ROMERO, R
    SENTI, M
    NOGUES, X
    PEDROBOTET, J
    RUBIESPRAT, J
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1992, 7 (07) : 623 - 626
  • [36] SERUM-LIPOPROTEIN (A) LEVELS IN PATIENTS WITH CHRONIC-RENAL-FAILURE - EVOLUTION AFTER RENAL-TRANSPLANTATION AND RELATIONSHIP WITH OTHER PARAMETERS OF LIPOPROTEIN METABOLISM - A PROSPECTIVE-STUDY
    SEGARRA, A
    CHACON, P
    MARTIN, M
    VILARDELL, M
    VILA, J
    COTRINA, M
    FORT, J
    OLMOS, A
    PIERA, LL
    NEPHRON, 1995, 69 (01): : 9 - 13
  • [37] DO ENDOCRINE ABNORMALITIES IN KIDNEY-TRANSPLANT PATIENTS AND PATIENTS WITH END-STAGE CHRONIC-RENAL-FAILURE INFLUENCE THE ELECTROLYTE-COMPOSITION OF SWEAT
    WOCH, W
    GRZESZCZAK, W
    WIECEK, A
    SZCZECHOWSKAZUKOWSKA, E
    KOKOT, F
    NIEREN-UND HOCHDRUCKKRANKHEITEN, 1993, 22 (01) : 9 - 12
  • [38] Distinct impact of vitamin D insufficiency on calcitriol levels in chronic renal failure and renal transplant patients: a role for FGF23?
    Mazzaferro, Sandro
    Pasquali, Marzia
    Pugliese, Francesco
    Citterio, Franco
    Gargiulo, Antonio
    Rotondi, Silverio
    Tartaglione, Lida
    Conte, Carmina
    Pirro, Giuliana
    Taggi, Franco
    JOURNAL OF NEPHROLOGY, 2012, 25 (06) : 1108 - 1118
  • [39] Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients
    Muniz-Junqueira, MI
    Lopes, CB
    Magalhaes, CA
    Schleicher, CC
    Veiga, JPR
    LIFE SCIENCES, 2005, 77 (25) : 3141 - 3155
  • [40] Associations of fractalkine receptor (CX3CR1) and CCR5 gene variants with hypertension, diabetes and atherosclerosis in chronic renal failure patients undergoing hemodialysis
    Bagci, Binnur
    Bagci, Gokhan
    Huzmeli, Can
    Sezgin, Ilhan
    Ozdemir, Ozturk
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2016, 48 (07) : 1163 - 1170